Frings, Marko http://orcid.org/0009-0001-5250-5751
Welsner, Matthias
Mousa, Christin
Zensen, Sebastian
Salhöfer, Luca
Meetschen, Mathias
Beck, Nikolas
Bos, Denise
Westhölter, Dirk
Wienker, Johannes
Taube, Christian
Umutlu, Lale
Schaarschmidt, Benedikt M.
Forsting, Michael
Haubold, Johannes
Sutharsan, Sivagurunathan
Opitz, Marcel
Article History
Received: 24 May 2024
Accepted: 2 August 2024
First Online: 19 September 2024
Declarations
:
: The study was conducted in accordance with the guidelines of the Declaration of Helsinki and received approval from the institutional review board (23-11602-BO). Informed consent was waived due to the retrospective study design. All chest CT scans were conducted using standard clinical protocols for diagnostic purposes, and patient information was anonymised.
: Not applicable.
: BMS has received a research grant from the Deutsche Forschungsgemeinschaft for an undergoing investigator-initiated study not related to this work as well as research grants from PharmaCept and the Else Kröner-Fresenius Foundation for a past investigator-initiated study not related to this work. BMS has received speaker fees from AstraZeneca and a travel Grant from Bayer AG. The other authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.